NC-TRILLIANT/TNB
Trilliant, a leading international provider of solutions for advanced metering infrastructure (AMI), smart grid, smart cities and IIoT, today announced that Tenaga Nasional Berhad (TNB), the largest electricity utility in Malaysia and a leading utility company in Asia, has extended their joint partnership. Trilliant will continue to support TNB as it further accelerates smart meter deployment nationally to meet its energy transition vision.
TNB and Trilliant first formed a strategic partnership in 2017 to support the utility company’s nationwide plan for smart meter deployment, along with a joint go-to-market strategy to drive innovation and deliver smart communications solutions to utilities across Asia Pacific and other select regions. This partnership provides TNB with the support it requires in the near future to continue its smart meter deployment, including access to Trilliant’s next generation AMI network technology and a five-year maintenance and support agreement.
Through their collaboration, Trilliant’s flexible solutions have helped TNB improve billing efficiency, enhance forecasting and planning, and improve outage management, positioning the utility to further augment customer-facing benefits while providing consumers with more control over their energy use.
“We value our longstanding partnership with TNB and are honoured to continue our work to support them as they progress towards their goals and innovative energy transition vision,” said Trilliant Chairman and CEO Andrew C. White. “Our organizations share a vision to drive positive change for a cleaner and more sustainable future. We’re proud to be a part of their journey as they advance the region towards Net Zero.”
“The urgency to accelerate energy transition is undeniable, and we cannot embark on this journey alone. We seek strategic partnerships with like-minded organisations like Trilliant, where complementary expertise coalesces to drive innovation. Together, we will forge an energy ecosystem that is deeply integrated, customer-centric, smart, hyper-connected, agile, and responsive to the sustainability challenges ahead,” said Dato’ Seri Ir. Baharin Din, President and CEO of Tenaga Nasional Berhad.
Driven by an unwavering commitment to sustainability and relentless innovation, TNB is spearheading the implementation of the energy transition, aligning with Malaysia's resolute agenda to combat climate change, safeguard continued business growth, and fast-track TNB's own sustainability aspirations of achieving net zero carbon emissions by 2050.
“Embracing the transformative power of technology and innovation, we are steadfastly modernising our digital foundations to seamlessly align with our energy transition strategy. This strategy is designed to tackle the energy trilemma across the value chain, fulfilling our commitment to sustainability and fostering business growth. Simultaneously, we are venturing into uncharted territories within the energy transition space, unwavering in our pursuit to accelerate generation decarbonisation, develop flexible and cross-border grid and empower cross-sector electrification and prosumers,” added Baharin.
Trilliant’s holistic program with TNB includes the Trilliant Communication Module — locally manufactured in Malaysia — embedded in every smart meter. Additionally, Trilliant has deployed a reliable network to support the high volume of traffic generated by the smart meters.
“TNB understands the significance of data, and our technology has provided them the ability to make timely, data-driven decisions, which in turn optimizes grid availability, reliability and planning — all while enabling advanced applications such as time-of-use rates, prepaid metering and demand response,” said Eugene Loke, Managing Director, APAC, at Trilliant. “Trilliant’s solutions efficiently and securely support organizations that are facing the energy transition, no matter where they are in their journey. We’re proud to work with innovative leaders like TNB, strengthening their strategies and helping them to achieve their objectives.”
The Power of Choice
Trilliant’s end-to-end portfolio of solutions offer utility companies and smart cities the Power of Choice. Its flexible, multi-tiered platform is device-agnostic and drives optimal endpoints and outcomes, enabling utilities to optimize assets and offer value-added services to customers. The flexibility provided by the Power of Choice allows Trilliant's customers to select endpoints from global manufacturers or support local job creation with in-country manufacturing.
Trilliant believes AMI applications go beyond just billing; they’re vital for operational efficiency and to meet the evolving expectations of consumers who desire more control over their energy use, cleaner and sustainable energy sources, and a reliable grid that can adapt to changing circumstances. The accelerated adoption of renewable energy and electric vehicles requires additional solutions supporting the energy transition, and the company is working with customers to enable applications including Distribution Automation; monitoring of Variable Renewable Energy generation; Distributed Energy Resources integration; smart street lighting; and EV capacity planning.
Trilliant will be at Enlit Asia November 14-16, 2023. Visit Booth 401 to experience innovative solution demos and speak with Trilliant subject matter experts. Trilliant will also be presenting at the event. For more information, visit https://trilliant.com/trilliant-to-focus-on-the-energy-transition-grid-modernization-and-ami-at-enlit-asia/.
To book a one-on-one demo and meeting with Trilliant at Enlit Asia, or for more information, contact info@trilliant.com.
To learn more about Trilliant’s smart grid solutions, visit: https://trilliant.com/smart-grid/.
For more about Trilliant’s AMI solutions, visit: https://trilliant.com/advanced-metering-infrastructure-ami/.
About Trilliant
Trilliant® empowers the global energy industry with the only device-agnostic communications platform that enables utilities and cities to deploy any application securely and reliably on one powerful network. Our purpose-built portfolio is designed to offer the power of choice, without risk of customers being “locked in” with one technology provider. We are proud to offer mission-critical solutions that support AMI, Data & Analytics, Smart Grids and Smart Cities. Customers worldwide benefit from Trilliant’s unique combination of flexibility, sustainability and scalability that connects utilities and cities to the IIOT and a more strategic path to the Energy Transition. Visit us at www.trilliant.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231114473465/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom